Skip to main content
. Author manuscript; available in PMC: 2019 Nov 27.
Published in final edited form as: ACS Appl Mater Interfaces. 2019 Feb 21;11(9):8849–8857. doi: 10.1021/acsami.8b21270

Figure 5: Increasing biochemical ligand density enhances osteogenic differentiation of hMSCs regardless of matrix stiffness.

Figure 5:

Increasing ligand density enhances expression of early osteogenic markers (a) ALP (Scale bar, 100 μm) and (b) and RUNX2 (green), indicated by nuclear localization (Scale bar, 30 μm).